THERAPEUTIC STRATEGIES FOR IMMUNOINFECTIVE CLUSTER VIRUS INFECTIONS

摘要

Therapeutic strategies for the treatment of immunoinfective cluster virus infections in humans involving the use of antibodies or fragments thereof which are characteristic of autoantibodies produced by patients affected with systemic rheumatic disorders and cross-react with epitopes on an immunoinfective cluster virus. Additional therapeutic strategies include the use of U1 RNA or fragments thereof to treat said viral infections.